Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 217, Issue 12
Volume 217, Issue 12
15 June 2018
ISSN 0022-1899
EISSN 1537-6613

Volume 217, Issue 12, 15 June 2018

EDITORIAL COMMENTARIES

Nargis Khan and Maziar Divangahi
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1851–1853, https://doi.org/10.1093/infdis/jix626
Art F Y Poon and Bethany L Dearlove
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1854–1857, https://doi.org/10.1093/infdis/jiy132
Curtis L Cooper
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1858–1860, https://doi.org/10.1093/infdis/jiy117
M R Schleiss
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1861–1864, https://doi.org/10.1093/infdis/jiy104

MAJOR ARTICLES AND BRIEF REPORTS

HIV/AIDS

Marcelo J Kuroda and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1865–1874, https://doi.org/10.1093/infdis/jix625

The rhesus macaque model of SIV and Mtb co-infection demonstrated that destruction of lung tissue macrophages promoted the transition from latent to reactivated Mtb. This was reflected by increased monocyte turnover that may be a predictive biomarker of Mtb reactivation.

Manon Ragonnet-Cronin and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1875–1882, https://doi.org/10.1093/infdis/jiy130

An outbreak of HIV among people who inject drugs in Scotland follows similar recent outbreaks in Greece, Romania, Ireland, and the United States. Phylodynamic analysis demonstrates the infections are tightly linked genetically and the effective reproductive number remains above 1.

Victoria P Strouvelle and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1883–1888, https://doi.org/10.1093/infdis/jiy131

Total HIV-1 DNA was quantified in HIV-1/HCV coinfected patients receiving pIFN-α treatment. Total HIV-1 DNA remained stable before, during, and after pIFN-α treatment, which questions the benefit of pIFN-α as an immunotherapeutic agent for reducing the HIV-1 reservoir.

VIRUSES

Francois M J Lamoury and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1889–1896, https://doi.org/10.1093/infdis/jiy114

This study demonstrated 100% sensitivity and specificity of the Xpert HCV VL FS test compared to the Abbott RealTime HCV Viral Load assay. This assay can detect active infection from a finger-stick sample in 1 hour, allowing single-visit HCV diagnosis.

Miriam Fritz and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1897–1901, https://doi.org/10.1093/infdis/jiy128

There is a paucity of data on extrahepatic manifestations of hepatitis E virus infection. This study describes the role of hepatitis E in patients with neuralgic amyotrophy and the associated pathological cerebrospinal fluid findings.

Parag Mahale and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1902–1906, https://doi.org/10.1093/infdis/jiy157

Hepatitis D viremia was present in 35.6% of injection drug users from San Francisco who had active hepatitis B virus infection. A novel hepatitis D virus quantitative microarray antibody assay demonstrated excellent performance characteristics in this population.

Ilona Baraniak and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1907–1917, https://doi.org/10.1093/infdis/jiy102

Human cytomegalovirus (HCMV) glycoprotein B (gB) generates a prodigious polyclonal antibody response in vivo. Patients with antibodies that detect antigenic domain 2 display reduced viraemia post transplant - levels of which are boosted in recipients of a recombinant gB vaccine.

Hana Guberina and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1918–1922, https://doi.org/10.1093/infdis/jix638

Cytomegalovirus (CMA) causes serious complications after transplantation. Genetic biomarkers are required for an improved individualized CMV-associated risk management. This study introduces HLA-E*01:03 allele carrier status, independent of CMV high-risk status, in transplant recipients as a prognostic factor for CMV infection after transplantation.

Zhiwei Liu and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1923–1931, https://doi.org/10.1093/infdis/jiy122

We found that healthy adults mount antibody responses targeting the full spectrum of the Epstein-Barr virus life cycle, that mucosal exposure to proteins can be influenced by smoking, and that a proportion of adults display antibody patterns that may predispose them to disease risk.

Jesica A Swanstrom and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1932–1941, https://doi.org/10.1093/infdis/jiy063

Here we provide qualitative measures of the magnitude and epitope specificity of the neutralizing antibody responses to live-attenuated tetravalent dengue vaccine (TDV). This information will be useful for understanding the performance of TDV in clinical trials and for identifying correlates of protective immunity.

Zhenjian He and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1942–1951, https://doi.org/10.1093/infdis/jiy129

This study shows that Zika virus, an emerging flavivirus, triggers NLRP3 inflammasome–mediated interleukin 1β production via interaction with NLRP3 and generation of reactive oxygen species, through action of the virus-encoded nonstructural protein 5.

Nicole Espy and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1952–1956, https://doi.org/10.1093/infdis/jiy163

Deep-sequencing analysis of Crimean-Congo hemorrhagic fever virus (CCHFV) from a patient with autochthonous infection identified ribavirin-mediated antiviral mutagenic activity in the CCHFV population. These findings support the continued evaluation of ribavirin as an antiviral therapy for CCHFV-infected patients.

Markus H Kainulainen and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1957–1966, https://doi.org/10.1093/infdis/jiy123

Lassa fever is a viral zoonosis with a high annual case number in West Africa. A vaccine candidate comprising particles that replicate only in the first cells encountered conferred complete protection in a small-animal model.

PARASITES

Hamtandi Magloire Natama and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1967–1976, https://doi.org/10.1093/infdis/jiy140

This study examined the potential benefits of malaria in pregnancy preventive strategies in infants and showed, that enhanced screening and treatment, in addition to standard intermittent preventive treatment with sulfadoxine-pyrimethamine, may provide additional protection against malaria and nonmalarial fevers in early infancy.

BACTERIA

Gyu-Lee Kim and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1977–1986, https://doi.org/10.1093/infdis/jiy158

IL-17A is the key factor for clearing extracellular bacteria; thus, a Th17-based vaccine could induce a Th17 response, followed bacterial burden reduction. Δpep27 vaccination induced IL-17A via Wnt signaling and inhibited pulmonary colonization, providing a novel protection against respiratory infections.

Lucille F van Beek and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1987–1996, https://doi.org/10.1093/infdis/jiy125

The Bordetella pertussis gene expression profile during respiratory infection of mice differs significantly from transcriptional profiles of in vitrocultured Bvg+ or Bvg- bacteria. Our study suggest that virulence-repressed genes may be more important during infection than previously assumed.

PATHOGENESIS AND HOST RESPONSE

Nadia Terrazzini and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 1997–2007, https://doi.org/10.1093/infdis/jiy096

IL-7 supports host immunity in lymphopenic and immunosuppressed patients and expands tumor-reactive T cells for adoptive immunotherapy. Here, we report that IL-7 also enables the accumulation of clinically relevant pathogen-reactive T cells from TB-, CMV-, and Candida albicans-infected individuals.

CORRESPONDENCE

Yuki Furuse
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 2008–2010, https://doi.org/10.1093/infdis/jiy154
Andreu Comas-García and others
The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 2010–2012, https://doi.org/10.1093/infdis/jiy155

ERRATUM

The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Page 2013, https://doi.org/10.1093/infdis/jiy162

ACKNOWLEDGMENTS

The Journal of Infectious Diseases, Volume 217, Issue 12, 15 June 2018, Pages 2014–2017, https://doi.org/10.1093/infdis/jiy172
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close